Glycosaminoglycans and neuroprotection

Handbook of Experimental Pharmacology

Volumn 207, Issue , 2012, Pages 325-343

  Dudas, B ^a   Semeniken, K ^b  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b Millcreek Community Hospital   (United States)

Author keywords

Alzheimer's disease; Apoptosis; Glycosaminoglycans; Neuroprotection; Oxidative stress; Parkinson's disease; Prion; Proteoglycans

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; GLYCOSAMINOGLYCAN; GLYCOSAMINOGLYCAN C3; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE; TAU PROTEIN; TILORONE; UNCLASSIFIED DRUG; AMYLOID;

ALZHEIMER DISEASE; AMYLOIDOSIS; APOPTOSIS; ARTICLE; DEGENERATIVE DISEASE; DNA FRAGMENTATION; HUMAN; LEWY BODY; LIPID PEROXIDATION; NEUROFIBRILLARY TANGLE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; POLYMERIZATION; PRION DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; SENILE PLAQUE; BIOSYNTHESIS; CHEMISTRY; CONFORMATION; METABOLISM; NERVOUS SYSTEM; REVIEW;

AMYLOID; APOPTOSIS; CARBOHYDRATE CONFORMATION; GLYCOSAMINOGLYCANS; HUMANS; NERVOUS SYSTEM;

EID: 84861858496     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-23056-1_14     Document Type: Article

References (122)

1. Adjou KT, Simoneau S, Sales N et al (2003) A novel generation of heparan sulfate mimetics for the treatment of prion diseases. J Gen Virol 84:2595-2603
2. Alaniz L, Rizzo M, Malvicini M et al (2009) Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response. Cancer Lett 278:9-16
3. Arrasate M, Perez M, Valpuesta JM et al (1997) Role of glycosaminoglycans in determining the helicity of paired helical filaments. Am J Pathol 151:1115-1122
4. Bae KH, Moon CW, Lee Y et al (2009) Intracellular delivery of heparin complexed with chitosang- poly(ethylene glycol) for inducing apoptosis. Pharm Res 26:93-100
5. Ban TA, Morey LC, Santini V (1991) Clinical investigations with ateroid in old-age dementias. Semin Thromb Hemost 17(Suppl 2):161-163
6. Ban TA, Morey LC, Fjetland OK et al (1992) Early manifestations of dementing illness: treatment with glycosaminoglycan polysulfate. Prog Neuropsychopharmacol Biol Psychiatry 16:661-676
7. Belmiro CL, Castelo-Branco MT, Melim LM et al (2009) Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats. J Biol Chem 284:11267-11278
8. Berry D, Lynn DM, Sasisekharan R et al (2004) Poly(beta-amino ester)s promote cellular uptake of heparin and cancer cell death. Chem Biol 11:487-498
9. Brezillon S, Venteo L, Ramont L et al (2007) Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma. Clin Exp Dermatol 32:405-416
10. Campo GM, Avenoso A, Campo S et al (2008a) Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice. Osteoarthritis Cartilage 16:1474-1483
11. Campo GM, Avenoso A, Campo S et al (2008b) NF-kB and caspases are involved in the hyaluronan and chondroitin-4-sulphate-exerted antioxidant effect in fibroblast cultures exposed to oxidative stress. J Appl Toxicol 28:509-517
12. Campo GM, Avenoso A, Campo S et al (2008c) The antioxidant effect exerted by TGF-1betastimulated hyaluronan production reduced NF-kB activation and apoptosis in human fibroblasts exposed to FeSo4 plus ascorbate. Mol Cell Biochem 311:167-177
13. Campo GM, Avenoso A, Campo S et al (2008d) Chondroitin-4-sulphate reduced oxidative injury in caerulein-induced pancreatitis in mice: the involvement of NF-kappaB translocation and apoptosis activation. Exp Biol Med (Maywood) 233:741-752
14. Campo GM, Avenoso A, Campo S et al (2008e) The antioxidant activity of chondroitin- 4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-kappaB and caspase activation. Br J Pharmacol 155:945-956
15. Campo GM, Avenoso A, Campo S et al (2009) Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem 106:83-92
16. Castillo GM, Ngo C, Cummings J et al (1997) Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J Neurochem 69:2452-2465
17. Caughey B (1994) Scrapie-associated PrP accumulation and agent replication: effects of sulphated glycosaminoglycan analogues. Philos Trans R Soc Lond B Biol Sci 343:399-404
18. Caughey B, Race RE (1994) Scrapie-associated PrP accumulation and its inhibition: revisiting the amyloid-glycosaminoglycan connection. Ann N Y Acad Sci 724:290-295
19. Caughey B, Raymond GJ (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67:643-650
20. Caughey B, Brown K, Raymond GJ et al (1994) Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]. J Virol 68:2135-2141
21. Chen X, Xiao W, Qu X et al (2008) The effect of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro. Cancer Invest 26:718-724
22. Cohlberg JA, Li J, Uversky VN et al (2002) Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. Biochemistry 41:1502-1511
23. Conti L, Placidi GF, Cassano GB (1989a) Ateroid in the treatment of dementia: results of a clinical trial. Mod Probl Pharmacopsychiatry 23:76-84
24. Conti L, Re F, Lazzerini F et al (1989b) Glycosaminoglycan polysulfate (Ateroid) in old-age dementias: effects upon depressive symptomatology in geriatric patients. Prog Neuropsychopharmacol Biol Psychiatry 13:977-981
25. Deepa PR, Varalakshmi P (2006) Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology 217:176-183
26. DeWitt DA, Silver J, Canning DR et al (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp Neurol 121:149-152
27. Diaz-Nido J, Wandosell F, Avila J (2002) Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides 23:1323-1332
28. Dudas B (2009) Low molecular weight glycosaminoglycans and apoptosis: potential treatment of neurodegenerative disorders including Alzheimer's Disease. Int J Med Biol Front 12:337-348
29. Dudas B, Cornelli U, Lee JM et al (2002) Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25-35)-induced abnormal tau protein immunoreactivity in rat brain. Neurobiol Aging 23:97-104
30. Dudas B, Rose M, Hanin I (2003) Dose-dependent effect of cholinotoxin AF64A on the cholinergic elements of the cingulum bundle in rat. Brain Res 965:295-298
31. Echigo R, Mochizuki M, Nishimura R et al (2006) Suppressive effect of hyaluronan on chondrocyte apoptosis in experimentally induced acute osteoarthritis in dogs. J Vet Med Sci 68:899-902
32. Erduran E, Tekelioglu Y, Gedik Y et al (1999) Apoptotic effects of heparin on lymphoblasts, neutrophils, and mononuclear cells: results of a preliminary in vitro study. Am J Hematol 61:90-93
33. Erduran E, Tekelioglu Y, Gedik Y et al (2004) In vitro determination of the apoptotic effect of heparin on lymphoblasts using DNA analysis and measurements of Fas and Bcl-2 proteins by flow cytometry. Pediatr Hematol Oncol 21:383-391
34. Erduran E, Deger O, Albayrak D et al (2007) In vitro investigation of the apoptotic effect of heparin on lymphoblasts by using flow cytometric DNA analysis and fluorometric caspase-3 and -8 activities. DNA Cell Biol 26:803-808
35. Fujii K, Fujii Y, Hubscher S et al (2001) CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells. J Immunol 167:1198-1203
36. Gabizon R, Meiner Z, Halimi M et al (1993) Heparin-like molecules bind differentially to prionproteins and change their intracellular metabolic fate. J Cell Physiol 157:319-325
37. Ganguly BJ, Tonomura N, Benson RM et al (2002) Hyperbaric oxygen enhances apoptosis in hematopoietic cells. Apoptosis 7:499-510
38. Ghatak S, Misra S, Toole BP (2002) Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 277:38013-38020
39. Goedert M, Jakes R, Spillantini MG et al (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383:550-553
40. Grishko V, Xu M, Ho R et al (2009) Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes. J Biol Chem 284:9132-9139
41. Guiroy DC, Yanagihara R, Gajdusek DC (1991) Localization of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses. Acta Neuropathol 82:87-92
42. Gupta-Bansal R, Frederickson RC, Brunden KR (1995) Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J Biol Chem 270:18666-18671
43. Haider AS, Grabarek J, Eng B et al (2003) In vitro model of wound healing analyzed by laser scanning cytometry: Accelerated healing of epithelial cell monolayers in the presence of hyaluronate. Cytometry A 53:1-8
44. Hasegawa M, Crowther RA, Jakes R et al (1997) Alzheimer-like changes in microtubuleassociated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J Biol Chem 272:33118-33124
45. Hijazi N, Kariv-Inbal Z, Gasset M et al (2005) PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J Biol Chem 280:17057-17061
46. Hills FA, Abrahams VM, Gonzalez-Timon B et al (2006) Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 12:237-243
47. Horonchik L, Tzaban S, Ben-Zaken O et al (2005) Heparan sulfate is a cellular receptor for purified infectious prions. J Biol Chem 280:17062-17067
48. Hosono K, Nishida Y, Knudson W et al (2007) Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol 171:274-286
49. Ishikawa Y, Kitamura M (1999) Inhibition of glomerular cell apoptosis by heparin. Kidney Int 56:954-963
50. Kaneko T, Saito H, Toya M et al (2000) Hyaluronic acid inhibits apoptosis in granulosa cells via CD44. J Assist Reprod Genet 17:162-167
51. Karti SS, Ovali E, Ozgur O et al (2003) Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparin. Hepatogastroenterology 50:1864-1866
52. Kisilevsky R, Szarek WA (2002) Novel glycosaminoglycan precursors as anti-amyloid agents part II. J Mol Neurosci 19:45-50
53. Kisilevsky R, Lemieux LJ, Fraser PE et al (1995) Arresting amyloidosis in vivo using smallmolecule anionic sulphonates or sulphates: implications for Alzheimer's disease. Nat Med 1:143-148
54. Kisilevsky R, Szarek WA, Ancsin J et al (2003) Novel glycosaminoglycan precursors as anti-amyloid agents, part III. J Mol Neurosci 20:291-297
55. Kisilevsky R, Szarek WA, Ancsin J et al (2004) Novel glycosaminoglycan precursors as antiamyloid agents: part IV. J Mol Neurosci 24:167-172
56. Kisilevsky R, Ancsin JB, Szarek WA et al (2007) Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications. Amyloid 14:21-32
57. Larramendy-Gozalo C, Barret A, Daudigeos E et al (2007) Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases. J Gen Virol 88:1062-1067
58. Leveugle B, Scanameo A, Ding W et al (1994) Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds. Neuroreport 5:1389-1392
59. Li HL, Ye KH, Zhang HW et al (2001) Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells. Cell Res 11:311-315
60. Li HL, Ren XD, Zhang HW et al (2002) Synergism between heparin and adriamycin on cell proliferation and apoptosis in human nasopharyngeal carcinoma CNE2 cells. Acta Pharmacol Sin 23:167-172
61. Lisignoli G, Grassi F, Zini N et al (2001) Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement. Arthritis Rheum 44:1800-1807
62. Liu IH, Uversky VN, Munishkina LA et al (2005) Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation. Glycobiology 15:1320-1331
63. Maeda S, Kimura H, Koga N et al (1993) Cell density-dependent DNA fragmentation and its suppression by heparin in primary culture of adult rat hepatocytes. Biochem Biophys Res Commun 195:270-275
64. Manaster J, Chezar J, Shurtz-Swirski R et al (1996) Heparin induces apoptosis in human peripheral blood neutrophils. Br J Haematol 94:48-52
65. Maneiro E, de Andres MC, Fernandez-Sueiro JL et al (2004) The biological action of hyaluronan on human osteoartritic articular chondrocytes: the importance of molecular weight. Clin Exp Rheumatol 22:307-312
66. Manero F, Ljubic-Thibal V, MoulinMet al (2004) Stimulation of Fas agonistic antibody-mediated apoptosis by heparin-like agents suppresses Hsp27 but not Bcl-2 protective activity. Cell Stress Chaperones 9:150-166
67. Mayer-Sonnenfeld T, Zeigler M, Halimi M et al (2005) The metabolism of glycosaminoglycans is impaired in prion diseases. Neurobiol Dis 20:738-743
68. Mayer-Sonnenfeld T, Avrahami D, Friedman-Levi Y et al (2008) Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time. Cell Mol Neurobiol 28:1005-1015
69. McBride PA, Wilson MI, Eikelenboom P et al (1998) Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of scrapie-infected mice. Exp Neurol 149:447-454
70. Ohashi R, Takahashi F, Cui R et al (2007) Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell. Cancer Lett 252:225-234
71. Pan T, Wong BS, Liu T et al (2002) Cell-surface prion protein interacts with glycosaminoglycans. Biochem J 368:81-90
72. Passeri M, Cucinotta D (1989) Ateroid in the clinical treatment of multi-infarct dementia. Mod Probl Pharmacopsychiatry 23:85-94
73. Pauloin T, Dutot M, Warnet JM et al (2008) In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride. Eur J Pharm Sci 34:263-273
74. Pauloin T, Dutot M, Joly F et al (2009) High molecular weight hyaluronan decreases UVBinduced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 15:577-583
75. Perez M, Valpuesta JM, MedinaMet al (1996) Polymerization of tau into filaments in the presence of heparin:the minimal sequence required for tau-tau interaction. J Neurochem 67:1183-1190
76. Perez M, Wandosell F, Colaco C et al (1998) Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment. Biochem J 335(Pt 2):369-374
77. Perry G, Richey P, Siedlak SL et al (1992) Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases. Brain Res 579:350-352
78. Pollack SJ, Sadler II, Hawtin SR et al (1995) Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci Lett 184:113-116
79. Priola SA, Caughey B (1994) Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol 8:113-120
80. Priola SA, Caughey B, Raymond GJ et al (1994) Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. Infect Agents Dis 3:54-58
81. Pumphrey CY, Theus AM, Li S et al (2002) Neoglycans, carbodiimide- modified glycosaminoglycans: A new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res 62:3722-3728
82. Rose M, Dudas B, Cornelli U et al (2003) Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats. Neurobiol Aging 24:481-490
83. Rose M, Dudas B, Cornelli U et al (2004) Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner. Brain Res 1015:96-102
84. Ruffell B, Johnson P (2008) Hyaluronan induces cell death in activated T cells through CD44. J Immunol 181:7044-7054
85. Sadler II, Hawtin SR, Tailor V et al (1995) Glycosaminoglycans and sulphated polyanions attenuate the neurotoxic effects of beta-amyloid. Biochem Soc Trans 23:106S
86. Santini V (1989) A general practice trial of Ateroid 200 in 8,776 patients with chronic senile cerebral insufficiency. Mod Probl Pharmacopsychiatry 23:95-100
87. Schonberger O, Horonchik L, Gabizon R et al (2003) Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis. Biochem Biophys Res Commun 312:473-479
88. Schonherr E, O'Connell BC, Schittny J et al (1999) Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 78:44-55
89. Shaffer LM, Dority MD, Gupta-Bansal R et al (1995) Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol Aging 16:737-745
90. Sheehan KM, DeLott LB, Day SM et al (2003) Hyalgan has a dose-dependent differential effect on macrophage proliferation and cell death. J Orthop Res 21:744-751
91. Sheehan KM, DeLott LB, West RA et al (2004) Hyaluronic acid of high molecular weight inhibits proliferation and induces cell death in U937 macrophage cells. Life Sci 75:3087-3102
92. Shimizu H, Sato S, Ohishi H et al (1997) Proteoglycans in senile dementia of Alzheimer's type. Nippon Ronen Igakkai Zasshi 34:461-467
93. Shyng SL, Lehmann S, Moulder KL et al (1995) Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J Biol Chem 270:30221-30229
94. Simonaro CM, Haskins ME, Schuchman EH (2001) Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: A possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab Invest 81:1319-1328
95. Snow AD, Kinsella MG, Parks E et al (1995) Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease. Arch Biochem Biophys 320:84-95
96. Spillantini MG, Tolnay M, Love S et al (1999) Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia. Acta Neuropathol 97:585-594
97. Takahashi K, Hashimoto S, Kubo T et al (2000) Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 27:1713-1720
98. Toole BP, Ghatak S, Misra S (2008) Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol 9:249-252
99. Tunjung WA, Yokoo M, Hoshino Y et al (2009) Effect of hyaluronan to inhibit caspase activation in porcine granulosa cells. Biochem Biophys Res Commun 382:160-164
100. Ueda K, Inoue S, Zhang Y et al (2009) Heparin induces apoptosis through suppression of AKt in oral squamous cell carcinoma cells. Anticancer Res 29:1079-1088
101. Uzun Y, Akdogan E, Ozdemir F et al (2009) The effects of heparin on DLD-1 colon cancer cell line. Bratisl Lek Listy 110:3-6
102. Van GD, David G, Lammens M et al (1993) Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer's and Lewy body type dementia. Dementia 4:308-314
103. van HJ, de Vos RA, Steur EN et al (2004) Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson's disease brains. J Alzheimers Dis 6:469-474
104. Vana K, Zuber C, Nikles D et al (2007) Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell Mol Neurobiol 27:107-128
105. Vij N, Roberts L, Joyce S et al (2004) Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. Exp Eye Res 78:957-971
106. Vij N, Roberts L, Joyce S et al (2005) Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling. Invest Ophthalmol Vis Sci 46:88-95
107. Vincent T, Molina L, Espert L et al (2003) Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma. Br J Haematol 121:259-269
108. Vuillermoz B, Khoruzhenko A, D'Onofrio MF et al (2004) The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res 296:294-306
109. Warner RG, Hundt C, Weiss S et al (2002) Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem 277:18421-18430
110. Wong C, Xiong LW, Horiuchi M et al (2001) Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J 20:377-386
111. Wu Y, Wu J, Lee DY et al (2005) Versican protects cells from oxidative stress-induced apoptosis. Matrix Biol 24:3-13
112. Wu M, Bian Q, Liu Y et al (2009) Sustained oxidative stress inhibits NF-kappaB activation partially via inactivating the proteasome. Free Radic Biol Med 46:62-69
113. Yamin G, Munishkina LA, Karymov MA et al (2005) Forcing nonamyloidogenic beta-synuclein to fibrillate. Biochemistry 44:9096-9107
114. Yang T, Witham TF, Villa L et al (2002) Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas. Cancer Res 62:2583-2591
115. Yasuda M, Tanaka Y, Fujii K et al (2001) CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells. Int Immunol 13:1309-1319
116. Yasuda M, Nakano K, Yasumoto K et al (2002) CD44: functional relevance to inflammation and malignancy. Histol Histopathol 17:945-950
117. Yin S, Yu S, Li C et al (2006) Prion proteins with insertion mutations have altered N-terminal conformation and increased ligand binding activity and are more susceptible to oxidative attack. J Biol Chem 281:10698-10705
118. +Yin S, Pham N, Yu S et al (2007) Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans. Proc Natl Acad Sci USA 104:7546-7551
119. Yu S, Yin S, Pham N et al (2008a) Ligand binding promotes prion protein aggregation - role of the octapeptide repeats. FEBS J 275:5564-5575
120. Yu TG, Zhang QZ, Zhang ZG et al (2008b) Protective effect of ultra low molecular weight heparin on glutamate-induced apoptosis in cortical cells. Yonsei Med J 49:486-495
121. Yue XL, Lehri S, Li P et al (2009) Insights on a new path of pre-mitochondrial apoptosis regulation by a glycosaminoglycan mimetic. Cell Death Differ 16:770-781
122. Zhou PH, Liu SQ, Peng H (2008) The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J Orthop Res 26:1643-1648